You are here

Women's Imaging

 

A U.K. study based on a departmental audit has confirmed previous research suggesting that MRI-detected small enhancing masses and new small enhancing foci, including those smaller than 5 millimeters, should be considered suspicious in women at high risk for breast cancer.

Most radiologists performing digital screening mammography in U.S. community practice are meeting or exceeding most of the American College of Radiology’s performance recommendations. However, almost half have higher abnormal interpretation rates (AIRs) than established benchmarks and ACR’s recommendations on that metric—and that’s a serious problem calling for a concerted effort to solve.  

Breast lesions seldom turn up incidentally in abdominal MRI scans. However, when they do, quite a few turn out to be malignant. Accordingly, radiologists interpreting women’s abdominal MRIs should be on the lookout for breast abnormalities.

A recent study published in the American Journal of Roentgenology examined one reason issues in women’s imaging may be so hard to follow: Hospitals aren’t using their own resources to educate patients. 

A new implant to treat women with breast cancer has been deemed effective by two independent studies, an encouraging development for the bioabsorbable marker branded as BioZorb.

 

Recent Headlines

For high-risk women, even small lesions on breast MRI call for prompt assessment and biopsy

A U.K. study based on a departmental audit has confirmed previous research suggesting that MRI-detected small enhancing masses and new small enhancing foci, including those smaller than 5 millimeters, should be considered suspicious in women at high risk for breast cancer.

Attention must be paid to high abnormal-interpretation rates in modern screening mammography

Most radiologists performing digital screening mammography in U.S. community practice are meeting or exceeding most of the American College of Radiology’s performance recommendations. However, almost half have higher abnormal interpretation rates (AIRs) than established benchmarks and ACR’s recommendations on that metric—and that’s a serious problem calling for a concerted effort to solve.  

Mammography more effective when compared to previous screenings

According to researchers at the University of California, the recall rate of screening mammography is greatly reduced when physicians compare present and past mammograms.

Breast lesions found incidentally on abdominal MRI shown cancerous at a considerable rate

Breast lesions seldom turn up incidentally in abdominal MRI scans. However, when they do, quite a few turn out to be malignant. Accordingly, radiologists interpreting women’s abdominal MRIs should be on the lookout for breast abnormalities.

Mammography info on hospital websites needs to be simplified

Few hospitals are providing information on mammography for patients at the recommended reading level or with references to professional guidelines, according to a study published in the journal AJR.

Hospitals can do more to teach patients about mammography

A recent study published in the American Journal of Roentgenology examined one reason issues in women’s imaging may be so hard to follow: Hospitals aren’t using their own resources to educate patients. 

Two studies validate efficacy of bioabsorbable breast cancer marker

A new implant to treat women with breast cancer has been deemed effective by two independent studies, an encouraging development for the bioabsorbable marker branded as BioZorb.

Making 3D mammography a reality for all facilities

Countless studies have shown 3D mammography can reduce false positives and increases cancer detection in women with dense breasts, it creates a better overall patient experience, and insurance companies are finally beginning to cover costs associated with 3D mammograms.

4 uses for contrast-enhanced spectral mammography

Researchers and clinicians from Cooper University Hospital have been using spectral mammography on a daily basis since November 2012. A group of residents, fellows and faculty from Cooper published a review of techniques and practical applications of contrast-enhanced spectral mammography (CESM) in Academic Radiology.

A game-changer is long overdue in breast-cancer research—and one may be just ahead

As far as we’ve come in the fight against breast cancer over the past 20 years, the state of actionable information is, circa 2016, fairly accurately encapsulated by an old bromide that’s often dispatched to denigrate perceptions of progress: The more things change, the more they stay the same.

Pages